Assié, G.
159  results:
Search for persons X
?
3

Gene expression profiling in adrenocortical neoplasia:

Assie, G. ; Giordano, T.J. ; Bertherat, J.
Molecular and Cellular Endocrinology.  351 (2012)  1 - p. 111-117 , 2012
 
?
7

Targeted metabolomics as a tool in discriminating endocrine..:

Erlic, Z ; Reel, P ; Reel, S...
info:eu-repo/semantics/altIdentifier/doi/10.1210/clinem/dgaa954.  , 2021
 
?
8

Corticotroph tumor progression after bilateral adrenalectom..:

Reincke, M ; Albani, A ; Assie, G...
Reincke , M , Albani , A , Assie , G , Bancos , I , Brue , T , Buchfelder , M , Chabre , O , Ceccato , F , Daniele , A , Detomas , M , Di Dalmazi , G , Elenkova , A , Findling , J , Grossman , AB , Gomez-Sanchez , CE , Heaney , AP , Honegger , J , Karavitaki , N , Lacroix , A , Laws , E R , Losa , M , Murakami , M , Newell-Price , J , Giraldi , FP , Perez-Rivas , LG , Pivonello , R , Rainey , WE , Sbiera , S , Schopohl , J , Stratakis , CA , Theodoropoulou , M , van Rossum , L , Valassi , E , Zacharieva , S , Rubinstein , G & Ritzel , K 2021 , ' Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations ' , European Journal of Endocrinology , vol. 184 , no. 2 , pp. P1-P16 . https://doi.org/10.1530/eje-20-1088.  , 2021
 
?
9

Targeted Metabolomics as a Tool in Discriminating Endocrine..:

Erlic Z ; Reel P ; Reel S...
info:eu-repo/semantics/altIdentifier/pmid/33382876.  , 2021
 
?
10

ENSAT registry-based randomized clinical trials for adrenoc..:

Crona, J ; Baudin, E ; Terzolo, M...
Crona , J , Baudin , E , Terzolo , M , Chrisoulidou , A , Angelousi , A , Ronchi , CL , Oliveira , CL , van Dijkum , E , Ceccato , F , Borson-Chazot , F , Reimondo , G , Tiberi , GAM , Ettaieb , H , Kiriakopoulos , A , Letizia , C , Kastelan , D , Osher , E , Yiannakopoulou , E , Arnaldi , G , Assie , G , Paiva , I , Bourdeau , I , Newell-Price , J , Nowak , KM , Romero , MT , de Martino , MC , Bugalho , MJ , Sherlock , M , Vantyghem , MC , Dennedy , MC , Loli , P , Rodien , P , Feelders , R A , de Krijger , R , Van Slycke , S , Aylwin , S , Morelli , V , Vroonen , L , Shafigullina , Z , Bancos , I , Trofimiuk-Muldner , M , Quinkler , M , Luconi , M , Kroiss , M , Naruse , M , Igaz , P , Mihai , R , Della Casa , S , Berruti , A , Fassnacht , M & Beuschlein , F 2021 , ' ENSAT registry-based randomized clinical trials for adrenocortical carcinoma ' , European Journal of Endocrinology , vol. 184 , no. 2 , pp. R51-R59 . https://doi.org/10.1530/EJE-20-0800.  , 2021
 
?
12

Adrenocortical carcinomas and malignant phaeochromocytomas:..:

Fassnacht M ; Assie G ; Baudin E...
info:eu-repo/semantics/altIdentifier/pmid/32861807.  , 2020
 
?
 
?
14

Adrenocortical carcinomas and malignant phaeochromocytomas:..:

Fassnacht, M ; Assie, G ; Baudin, E...
Fassnacht , M , Assie , G , Baudin , E , Eisenhofer , G , de la Fouchardiere , C , Haak , H R , de Krijger , R , Porpiglia , F , Terzolo , M , Berruti , A & ESMO Guidelines Committee 2020 , ' Adrenocortical carcinomas and malignant phaeochromocytomas : ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 31 , no. 11 , pp. 1476-1490 . https://doi.org/10.1016/j.annonc.2020.08.2099.  , 2020
 
?
15

European Society of Endocrinology Clinical Practice Guideli..:

Fassnacht M ; Dekkers OM ; Else T...
info:eu-repo/semantics/altIdentifier/pmid/30299884.  , 2018
 
1-15